Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;8(8):e2526714.
doi: 10.1001/jamanetworkopen.2025.26714.

Views Toward Pharmacogenomic Testing Among Patients With Cancer

Sharon P Shriver  1 , Sarah Long  1 , Mark E Fleury  1
Affiliations

Views Toward Pharmacogenomic Testing Among Patients With Cancer

Sharon P Shriver et al. JAMA Netw Open. .
No abstract available

Plain language summary

This survey study assesses views and understanding of pharmacogenomic testing among patients with cancer and cancer survivors.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Shriver reported receiving grants from the American Clinical Laboratory Association, AdvaMed, Amgen, Bayer, Boehringer Ingelheim, Bristol Meyers Squibb, Castle BioSciences, Daiichi Sankyo, Genentech, Guardant Health, Ipsen, Lilly, Memorial Sloan Kettering Cancer Center, Myriad, Natera, Pfizer, and Quest Diagnostics outside the submitted work. Ms Long reported grants from Bristol Myers Squibb fund a portion of her salary through institutional grants to her employer. Dr Fleury reported grants from Amgen, Bristol Myers Squibb, Parexel, and Cell Centric outside the submitted work.

References

    1. Paulsen NH, Pfeiffer P, Ewertz M, et al. Implementation and clinical benefit of DPYD genotyping in a Danish cancer population. ESMO Open. 2023;8(1):100782. doi: 10.1016/j.esmoop.2023.100782 - DOI - PMC - PubMed
    1. Russell C, Campion M, Grove ME, et al. Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing. Clin Transl Sci. 2024;17(3):e13737. doi: 10.1111/cts.13737 - DOI - PMC - PubMed
    1. Shriver SP, Adams D, McKelvey BA, et al. Overcoming barriers to discovery and implementation of equitable pharmacogenomic testing in oncology. J Clin Oncol. 2024;42(10):1181-1192. Published online February 22, 2024. doi: 10.1200/JCO.23.01748 - DOI - PMC - PubMed
    1. American Cancer Society Cancer Action Network Survivor views. Accessed July 8, 2025. https://www.fightcancer.org/survivor-views
    1. U.S. Food and Drug Administration . Patient-focused drug development: methods to identify what is important to patients. Published February 2022. Accessed March 6, 2025. https://www.fda.gov/media/131230/download